Last edition
News about "Ligand and Enhancer Assisted Delivery (LEAD) platf"
Eli Lilly and SanegeneBio Partner to Develop RNAi Therapies for Metabolic Diseases
SanegeneBio, a clinical-stage biotechnology company developing RNAi therapeutics, has entered into a global research and licensing collaboration with Eli Lilly and Company to advance RNAi candidates for metabolic diseases.
Ligand And Enhancer Assisted Delivery (LEAD) Platf | 10/11/2025 | By Dineshwori
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members